BioSpace News Archive

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that it has been awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company’s Sheboygan, Wisconsin site.

Leonhardt Ventures LLC, an innovation and venture creation company focused on the convergence of bioelectrics and biologics for organ regeneration, announced today that additional pre-clinical supporting data for the expression of the S100A1 protein was submitted to a patent application filed earlier this year.

The global specialty medical chairs market is estimated to experience a notable rise in the span of coming years, says TMR.

The point-of-care diagnostics market is expected to observe good growth prospects during the forecast period of 2016-2024.

Facial injectable or injectable dermal filler for face has been popularly used a minimally invasive cosmetic procedure for facial rejuvenation.

Changing lifestyle habits and excess consumption of alcohol and tobacco by a large population across the globe in addition to a sedentary lifestyle is driving the cardiac arrest treatment market toward growth.

Fact.MR – A Market Research and Competitive Intelligence Provider: Sales of global dual chamber prefilled syringes are projected to reach US$ 3.3 Bn over the forecast period from 2017 to 2026, predicts Fact.MR.

Seegene Inc., South Korea’s leading molecular diagnostics company, announced it will deliver COVID-19 testing reagents by a private plane to Israel that is experiencing acute shortages related to the resurgence of new cases due to the Omicron variant.

Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference.

Following Complete Clearance of Cancer Lesions in Advanced Liver Cancer Patient, Can-Fite is Filing Patent Applications for the Treatment of Various Advanced Solid Tumors.